Publications by authors named "Andrew Brohl"

Claim this Profile
R
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy.
Michelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, Jacob Israeli, Kimberly R Ward, Andrew S Brohl

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node Biopsy.
Michelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, Jacob Israeli, Kimberly R Ward, Andrew S Brohl

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients.
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, Kimberly Ward, Jamie Chau, Andrew S Brohl

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M Campbell, Andrew S Brohl

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M Campbell, Andrew S Brohl

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEBPB, C19MC, and Defective Autophagy Drive Novel Podosomal Belt to Macropinocytosis Transition, Lipid Accumulation, and HBV A-to-I RNA-editing.
Goodwin Jinesh, Nino Mtchedlidze, Varsha Devarapalli, Santanu Adhikary, John Lockhart, Andrew Brohl

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chromosome 19 microRNA Cluster Facilitates Cancer Stemness in Hepatocellular Carcinoma.
Marian T Underwood, Varsha Devarapalli, Goodwin G Jinesh, John H Lockhart, Marco Napoli, Andrew S Brohl

Noncoding RNA· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and Clinical Outcome of a Patient With Spindle Cell Rhabdomyosarcoma Harboring MEIS1-FOXO1 Gene Fusion.
Rebecca Mathew, Rachel K Voss, Arash O Naghavi, Evita Henderson-Jackson, Andrew S Brohl

Cureus· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.
Alex Soupir, Oscar E Ospina, Oliver Hampton, Michelle Churchman, Michael Radmacher, Andrew S Brohl

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal.
Andrew S Brohl

BMJ Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.
John Michael Bryant, Matthew N Mills, Casey Liveringhouse, Russell Palm, Mihaela Druta, Andrew Brohl

Radiother Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C19MC drives nucleolar invasion of mitochondria and meiotic nuclear division in human cancers.
Goodwin G Jinesh, Marian T Smallin, Nino Mtchedlidze, Marco Napoli, John H Lockhart, Andrew S Brohl

iScience· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma.
Sandra P D'Angelo, Céleste Lebbé, Paul Nghiem, Andrew S Brohl, Thomas Mrowiec

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.
Zachary Z Reinstein, Yue Zhang, Oscar E Ospina, Matt D Nichols, Victoria A Chu, Andrew S Brohl

Cancer Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma.
Tanya Ramadoss, Matthew Nichols, Christian Palacios, Zeynep Eroglu, Joseph Markowitz, Andrew S Brohl

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor.
Alison H Kucharik, Nina B Curkovic, Julio C Chavez, Kenneth Y Tsai, Andrew S Brohl

JAAD Case Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu

Mol Cancer Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and patient-reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy.
Aasha I Hoogland, Andrew S Brohl, Brent J Small, Lauren Michael, Evan Wuthrick

Cancer Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Danielle B Tometich, Carley Geiss, Melinda L Maconi, Melody Chavez, Aasha I Hoogland, Andrew S Brohl

Support Care Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C19MC miRNA-520G induces antiviral gene transcription and inhibits melanin production in skin cutaneous melanoma.
Goodwin G Jinesh, Marian T Smallin, Nino Mtchedlidze, Isha Godwin, Marco Napoli, Andrew S Brohl

Genes Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.
Zeynep Eroglu, Y Ann Chen, Inna Smalley, Jiannong Li, Joseph K Markowitz, Andrew S Brohl

Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.
Joanna Baginska, Allison Nau, Ilana Gomez Diaz, Anita Giobbie-Hurder, Jason Weirather, Andrew S Brohl

Cancer Immunol Immunother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.
Darcy L Welch, Brooke L Fridley, Ling Cen, Jamie K Teer, Sean J Yoder, Andrew S Brohl

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?
Ruoyu Miao, Jennifer Swank, Dan Melzer, Steven Ludlow, Leah Clark, Andrew S Brohl

Cancer Immunol Immunother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.
Julian A Marin-Acevedo, Bethany M Withycombe, Youngchul Kim, Andrew S Brohl, Zeynep Eroglu

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis